ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,724.00
-0.26%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Emergent Biosolutions Inc (EBS)

  7. Emergent Biosolutions Inc (EBS) Noticias

EBS Emergent Biosolutions Inc

3.88
0.58 (17.58%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Emergent Biosolutions Inc EBS NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.58 17.58% 3.88 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.45 3.36 4.02 3.89 3.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
01/5/202415:10GLOBEEmergent BioSolutions Announces Strategic Operational..
01/5/202410:03GLOBEEmergent BioSolutions Releases New Survey Findings..
30/4/202416:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
22/4/202407:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
01/4/202407:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
28/3/202407:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
25/3/202407:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
08/3/202415:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202419:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
06/3/202415:15EDGAR2Form 8-K - Current report
06/3/202405:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
04/3/202417:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202406:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
27/2/202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202419:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202406:25EDGAR2Form 8-K - Current report
21/2/202406:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
11/1/202406:41EDGAR2Form 8-K - Current report
09/1/202407:40EDGAR2Form 8-K - Current report
09/1/202406:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
27/12/202305:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
11/12/202316:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/12/202306:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202306:15EDGAR2Form 8-K - Current report
28/11/202305:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
24/11/202306:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
24/11/202306:17EDGAR2Form 8-K - Current report
16/11/202315:11EDGAR2Form 8-K - Current report
14/11/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202318:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202315:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
08/11/202316:38GLOBEEmergent BioSolutions Reports Third Quarter 2023 Financial..
08/11/202315:21EDGAR2Form 8-K - Current report
30/10/202315:45GLOBEUPDATE: Emergent BioSolutions to Release Third Quarter 2023..
19/10/202305:30GLOBEEmergent BioSolutions to Release Third Quarter 2023..
16/10/202306:00PRNUSEmergent BioSolutions Partners with Emmitt Smith to Launch..
05/10/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202318:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202318:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202306:42EDGAR2Form 8-K - Current report
02/10/202306:49EDGAR2Form 8-K - Current report
02/10/202306:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
30/8/202305:30EDGAR2Form 8-K - Current report
30/8/202304:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..

Su Consulta Reciente

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados